The two recent announcements by FDA and NIH are the catalyst needed to jump start biotech productivity through the adoption of New Approach Methodologies (NAMs): These announcements build upon more ...
A rendering of the Dexter Yard project. (SkB Architects Rendering) A big new project near Amazon’s Seattle headquarters could provide some relief to biotech and life sciences companies searching the ...
SINGAPORE, Aug. 4, 2025 /PRNewswire/ -- Tikva Allocell (Tikva), a biotechnology company developing off-the-shelf CAR-T cell therapies for solid tumors, today announced that its Founder and CEO, Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback